UTAH MEDICAL PRODUCTS INC (UTMD)
US9174881089 - Common Stock
| TTM (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 16.38M | 16.64M | 16.47M | 14.79M | 10.80M | |||
| Depreciation Amortization | 5.22M | 6.32M | 7.03M | 7.29M | 7.18M | |||
| Income Taxes - Deferred | -885.00K | -693.00K | -400.00K | -90.00K | -30.00K | |||
| Change In Working Capital | -374.00K | -233.00K | -2.23M | -1.01M | 1.99M | |||
| Interest Paid | 0.00 | 0.00 | N/A | 0.00 | 0.00 | |||
| Taxes Paid | 4.80M | 4.83M | 4.97M | 4.62M | 3.19M | |||
| Other non cash items | 281.00K | 257.00K | 270.00K | 230.00K | 200.00K | |||
| OPERATING CASH FLOW | 20.64M | 22.28M | 21.15M | 21.20M | 20.14M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -621.00K | -639.00K | -820.00K | -550.00K | -860.00K | |||
| Other Investing Activity | N/A | N/A | N/A | N/A | N/A | |||
| INVESTING CASH FLOW | -594.00K | -639.00K | -820.00K | -550.00K | -860.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | -2.80M | 117.00K | -2.32M | 560.00K | -6.62M | |||
| Dividend Paid | -4.30M | -4.28M | -3.16M | -11.47M | -4.12M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | -7.10M | -4.17M | -5.48M | -10.91M | -10.73M | |||
| Exchange Rate Effect | -59.00K | 339.00K | -770.00K | -360.00K | 260.00K | |||
| CHANGE IN CASH | 12.89M | 17.82M | 14.08M | 9.38M | 8.81M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 20.64M | 22.28M | 21.15M | 21.20M | 20.14M | |||
| Capital Expenditure | -621.00K | -639.00K | -820.00K | -550.00K | -860.00K | |||
| FREE CASH FLOW | 20.02M | 21.64M | 20.33M | 20.65M | 19.28M | |||
All data in USD